Alexandria Real Estate Equities, Inc. which can be found using ticker (ARE) have now 13 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between $186.00 and $118.00 suggesting an average analyst share price target price of $140.92. (at the time of writing). Now with the previous closing price of $126.87 this indicates there is a potential upside of 11.1%. It’s also worth noting that there is a 50 day moving average of $122.73 and the 200 day MA is $115.01. The market cap for the company is 22.03B. The stock price is currently at: $125.95 USD
The potential market cap would be $24,474,335,682 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 233.24, revenue per share of $16.89 and a 1.27% return on assets.
Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT). The Company owns, operates, develops and is focused on collaborative life science, agtech, and technology campuses in various cluster locations. It develops urban cluster campuses and ecosystems. Its properties are primarily located in various locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. It has approximately 432 properties in North America containing approximately 47.4 million rentable square feet (RSF) of operating properties and development and redevelopment of new Class A properties (under construction), including 64 properties that are held by consolidated real estate joint ventures and four properties that are held by unconsolidated real estate joint ventures. Its properties include 601, 611, and 651 Gateway Boulevard; Alexandria Center for Life Science-Durham; 275 Grove Street; SD Tech by Alexandria, and Other.
